Turning Point Therapeutics, Inc. Proceeds from Stock Options Exercised
Turning Point Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $709.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2019-11-04
- Turning Point Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2019-09-30 was $96.00K, a 269.23% increase year-over-year.
- Turning Point Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2019-06-30 was $591.00K, a 1415.38% increase year-over-year.
- Turning Point Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2019-03-31 was $22.00K, a 266.67% increase year-over-year.
- Turning Point Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2018-09-30 was $26.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month |
|---|---|---|---|
| 2019-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $687.00K derived: sum of 2 quarters · filed 2019-11-04 | $709.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $613.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $22.00K 10-Q · filed 2019-05-31 | ||
| 2018-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $65.00K derived: sum of 2 quarters · filed 2019-11-04 | $71.00K 10-Q · filed 2019-11-04 |
| 2018-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $45.00K 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $6.00K 10-Q · filed 2019-05-31 |